Design, theoretical study, druggability, pharmacokinetics and properties evolution of a new organo-bromocadmate compound as prospective anticancer agent - Université de Lille Accéder directement au contenu
Article Dans Une Revue Journal of Molecular Structure Année : 2023

Design, theoretical study, druggability, pharmacokinetics and properties evolution of a new organo-bromocadmate compound as prospective anticancer agent

Résumé

Crystals of the organic-inorganic hybrid complex [H3NCH2(C5H4NH)]2CdBr6·2H2O ([H3NCH2(C5H4NH)] = diprotonated 3-picolylamine or 3-ampH2), were grown successfully by slow evaporation solution growth method at room temperature and characterized by single-crystal X-ray diffraction, infrared absorption, optical absorption and thermal analysis. The title compound belongs to the triclinic space group P1 ̅, with a crystal structure consisting of inorganic layers built up from hexabromocadmate anions [CdBr6]4- and free water molecules, linked together by O-H···Br hydrogen bonds and halogen···halogen interactions, along the b axis. The organic cations, 3-ampH2, are intercalated between the mineral layers via N-H···Br hydrogen bonds. The optimized molecular structure and the vibrational spectra were calculated thanks to the Density Functional Theory (DFT) method resorting to the B3LYP function with the LanL2DZ basis set. Infrared spectrum was used to gain more information of the title compound, with the assignment of the observed vibration modes. Good agreement has been found between the calculated results and the experimental data. Subsequently, the optical properties were diagnosed throughout optical absorption explaining the possible charge transfer interactions that happen within the molecules. The thermal behavior was studied by TG/DT analyses. In silico analyses showed that the synthesized compound bound several anticancer receptors (TNF-α, COX-2, VEGF...) with high affinities, which together with molecular interactions, druggability and pharmacokinetics satisfactory explain the anticancer potential of the compound.
Fichier principal
Vignette du fichier
Manuscript_revised.pdf (652.14 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04313434 , version 1 (14-12-2023)

Identifiants

Citer

Noureddine Mhadhbi, Souad Dgachi, Soufienne Belgacem, Ali Ben Ahmed, Natacha Henry, et al.. Design, theoretical study, druggability, pharmacokinetics and properties evolution of a new organo-bromocadmate compound as prospective anticancer agent. Journal of Molecular Structure, 2023, Journal of Molecular Structure, pp.134439. ⟨10.1016/j.molstruc.2022.134439⟩. ⟨hal-04313434⟩
25 Consultations
10 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More